Table 1.
All (n) | Mean | SD | Men (n) | Mean | SD | Women (n) | Mean | SD | P value (sex) | |
---|---|---|---|---|---|---|---|---|---|---|
Age, y | 136 | 22.1 | 2.2 | 45 | 22.3 | 2.3 | 91 | 21.9 | 2.2 | 0.319 |
ANTHROPOMETRY AND BODY COMPOSITION | ||||||||||
Waist circumference, cm | 130 | 81.0 | 13.8 | 43 | 89.9 | 15.2 | 87 | 76.5 | 10.5 | <0.001 |
BMI, kg/m2 | 136 | 24.9 | 4.6 | 45 | 26.8 | 5.5 | 91 | 23.9 | 3.7 | 0.002 |
LBM, kg | 136 | 41.8 | 9.7 | 45 | 52.8 | 7.2 | 91 | 36.3 | 5.0 | <0.001 |
LMI, kg/m2 | 136 | 14.7 | 2.4 | 45 | 17.2 | 2.1 | 91 | 13.5 | 1.4 | <0.001 |
FMI, kg/m2 | 136 | 8.8 | 3.0 | 45 | 8.1 | 3.6 | 91 | 9.1 | 2.7 | 0.094 |
Body fat mass, kg | 136 | 24.7 | 8.8 | 45 | 24.8 | 11.0 | 91 | 24.6 | 7.5 | 0.884 |
Body fat percentage, % | 136 | 35.5 | 7.6 | 45 | 29.7 | 7.6 | 91 | 38.3 | 5.9 | <0.001 |
VAT mass, g | 136 | 336 | 174 | 45 | 418 | 176 | 91 | 296 | 159 | <0.001 |
CLINICAL PARAMETERS | ||||||||||
Glucose, mg/dL | 132 | 87.6 | 6.6 | 43 | 88.9 | 7.4 | 89 | 87.0 | 6.1 | 0.134 |
Insulin, μIU/mL | 132 | 8.3 | 4.9 | 43 | 9.1 | 6.4 | 89 | 8.0 | 4.0 | 0.638 |
Total cholesterol, mg/dL | 132 | 165 | 32 | 43 | 160 | 31 | 89 | 168 | 33 | 0.183 |
HDL-C, mg/dL | 132 | 53 | 11 | 43 | 46 | 7 | 89 | 56 | 11 | <0.001 |
LDL-C, mg/dL | 132 | 96 | 25 | 43 | 97 | 26 | 89 | 96 | 25 | 0.990 |
Triglycerides, mg/dL | 132 | 83 | 45 | 43 | 88 | 47 | 89 | 80 | 43 | 0.313 |
HOMA index | 132 | 1.8 | 1.2 | 43 | 2.1 | 1.6 | 89 | 1.7 | 1.0 | 0.562 |
C-reactive protein, mg/L | 132 | 2.4 | 3.4 | 43 | 2.1 | 2.3 | 89 | 2.5 | 3.8 | 0.937 |
Systolic pressure, mm Hg | 134 | 117 | 12 | 44 | 125 | 11 | 90 | 113 | 10 | <0.001 |
Diastolic pressure, mm Hg | 134 | 70.9 | 7.6 | 44 | 72.2 | 9.2 | 90 | 70.3 | 6.7 | 0.185 |
Data are presented as mean and SD. P values are obtained from analyses of the variance after log10 transformation of all blood parameters.
Abbreviations: ATP III, National Cholesterol Education Program Adult Treatment Panel III; BMI, body mass index; FMI, fat mass index; HDL-C, high-density lipoprotein cholesterol; HOMA, homeostatic model assessment; LDL-C, low-density lipoprotein cholesterol; LMI, lean mass index; VAT, visceral adipose tissue.